Cardiovascular

Innovative approaches are offering new hope for prevention and even reversal of cardiovascular disease. Unlike the conventional approach that often focuses on isolated risk factors such as high cholesterol or hypertension, personalized Swiss medicine considers the whole spectrum of influences that contribute to cardiovascular health.

These factors encompass a wide range, including chronic inflammation, poor dietary habits, physical inactivity, stress, sleep disturbances, genetic predispositions,environmental toxins and more. Recognizing this diversity is crucial in our treatment methodology.

By identifying and addressing these interrelated factors, our method aims to not just manage the symptoms but also to address the root causes of cardiovascular disease. This approach is tailored to each individual, enhancing the body’s innate healing ability and promoting overall heart health.

With cardiovascular disease being a leading cause of mortality globally and its development often silent and gradual, the emphasis on early intervention cannot be overstated. It’s essential to initiate proactive measures for heart health as early as possible.

Chelation Therapy for Toxicity:

An advanced detoxification treatment designed to support cardiovascular wellness by removing harmful metals and toxins from the bloodstream. Using EDTA, a chelating agent, this therapy binds to these toxic elements, allowing the body to naturally flush them out, reducing arterial plaque and enhancing vessel elasticity. Ideal for anyone looking to improve circulation, protect heart health, or promote overall wellness. A 2022 publication by the Journal of the American Heart Association has shown than 17 studies suggested improved outcomes and repeated EDTA for CVD treatment may provide more benefit to patients with diabetes and severe peripheral arterial disease. You can read more about Chelation therapy from Ana Navas-Acien, MD, PhD, and Filippo Ravalli, BA, Columbia University, Mailman School of Public Health, Columbia University: New York in the published Journal below.

Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review, Journal of the American Heart Association (2022)